Table 4 Association of TFQIFT4 and PTFQIFT4 with CTM risk.

From: Chronic thyrotoxic myopathy development is associated with thyroid hormone sensitivity index, predicted by lower-limb fatigue and the squat-up test

 

Model 1

Model 2

Model 3

OR

95% CI

OR

95% CI

OR

95% CI

TFQIFT4

6.64

2.29–19.20*

7.56

2.47–23.10*

3.22

0.89–11.67

TFQIFT4 (quartile)

Q1

Ref

 

Ref

 

Ref

 

Q2

2.67

1.04–6.85*

2.84

1.08–7.48*

4.07

1.24–13.36*

Q3

5.97

2.28–15.64*

6.97

2.54–19.13*

6.85

1.97–23.85*

Q4

5.37

2.06–13.96*

6.04

2.22–16.42*

3.57

1.10-11.54*

P for trend

8.46

2.80-25.52*

9.88

3.09–31.52*

4.35

1.14–16.49*

Per SD increase

1.79

1.29–2.49*

1.87

1.32–2.64*

1.43

0.96–2.14

PFTQIFT4

5.92

2.10-16.72*

6.63

2.22–19.75*

2.97

0.85–10.43

PTFQIFT4 (quartile)

Q1

Ref

 

Ref

 

Ref

 

Q2

2.67

1.04–6.85

2.84

1.08–7.47*

4.18

1.26–13.84*

Q3

7.75

2.91–20.60

9.12

3.26–25.47*

8.96

2.53–31.84*

Q4

4.19

1.62–10.83*

4.64

1.71–12.60*

2.78

0.84–9.16

P for trend

7.09

2.37–21.17*

8.26

2.61–26.10*

3.71

0.98–14.04

Per SD increase

1.75

1.26–2.45*

1.82

1.28–2.57*

1.41

0.95–2.10

  1. CTM, chronic thyrotoxic myopathy; TFQIFT3, thyroid feedback quantile-based index calculated by free triiodothyronine; PTFQIFT3, parametric thyroid feedback quantile-based index calculated by free triiodothyronine; OR, odd ratio; CI, confidence interval.
Back to article page